From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

STIMULATE-ICP or Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways is a large research consortium running a number of trials to improve the diagnosis, treatment and care of Long COVID patients.[1][2]

Aims[edit | edit source]

According to STIMULATE-ICP:

"The overall programme aims to work out what long COVID is, how to diagnose it and how to manage it. The team will interview patients and health professionals and analyse data from NHS records,to inform understanding of patterns of long COVID and the outcomes of current clinical practice. Researchers will work alongside patients to improve access to care and support, and to address care inequalities."[1]

Consortium members[edit | edit source]

Over 30 different researchers and 30 different organizations are involved, including the LongCovidSOS and UK Doctors #Longcovid long COVID patient groups and the British Heart Foundation charity, a number of British universities and UK NHS hospital trusts, plus several industry partners.[1]

Clinical trials[edit | edit source]

A number of different clinical trials will be run by STIMULATE-ICP, involving over 4,500 patients, and will include:

Notable people[edit | edit source]

Lead investigators[edit | edit source]

Other investigators[edit | edit source]

News articles and interviews[edit | edit source]

Notable studies[edit | edit source]

Funding[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 "STIMULATE-ICP: Understanding long COVID to improve diagnosis, treatment and care". ARC North Thames. Retrieved January 3, 2022.
  2. "New clinical trial aims to improve diagnosis, treatment and rehabilitation of long COVID". ARC North Thames. Retrieved January 3, 2022.
  3. 3.0 3.1 3.2 "FAQ". STIMULATE-ICP. Retrieved January 3, 2022.
  4. "COVID-19 research". ARC North Thames. Retrieved January 3, 2022.